IMCC | IM Cannabis Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.2200 - 2.4001
52 Week Range	1.1340 - 8.10
Beta	1.80
Implied Volatility	503.67%
IV Rank	90.99%
Day's Volume	18,886
Average Volume	27,187
Shares Outstanding	2,232,360
Market Cap	5,089,781
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2020-05-20

Valuation
Profitability
Growth
Health
P/E Ratio	-0.49
Forward P/E Ratio	N/A
EPS	-4.68
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	95
Country	Israel
Website	IMCC

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

IMCC's peers: GHSI, CLVR, KHRNF, ALID, BFRI, UPC, QLI, RAPH, GSAC, AAWH, IXHL, SSIC, PAHC, SUPN

*Chart delayed

Analyzing fundamentals for IMCC we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see IMCC Fundamentals page.

Watching at IMCC technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on IMCC Technicals page.